EIF3A and lung cancer: Previous studies, including our own study, supported the hypothesis that eIF3a knockdown reduces the cellular response to cisplatin by regulating the expression of DNA repair proteins in lung cancer (Yin et al., 2011a), nasopharyngeal carcinoma (Liu et al., 2011), and ovarian cancer (Zhang Y. et al., 2015).